Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
CYTK — Price & Forward EBITDA
Forward EBITDA (M)

Float Short %

13.01

Margin Of Safety %

Put/Call OI Ratio

0.32

EPS Next Q Diff

-0.17

EPS Last/This Y

0.01

EPS This/Next Y

1.6

Price

65.5

Target Price

93.22

Analyst Recom

1.33

Performance Q

6.89

Upside

-449.0%

Beta

0.46

Ticker: CYTK



19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-03-09CYTK62.410.240.03101442
2026-03-10CYTK64.240.240.41102724
2026-03-11CYTK63.60.240.05106273
2026-03-12CYTK60.020.242.84110580
2026-03-13CYTK600.242.85110580
2026-03-17CYTK62.160.280.89122620
2026-03-18CYTK62.230.290.36125670
2026-03-19CYTK62.930.302.77126959
2026-03-20CYTK61.690.320.20129882
2026-03-23CYTK60.940.300.70114553
2026-03-24CYTK60.040.300.27116909
2026-03-25CYTK62.370.300.07118466
2026-03-26CYTK63.470.301.11119785
2026-03-27CYTK62.520.300.75121370
2026-03-30CYTK62.960.310.54123755
2026-03-31CYTK65.880.320.14124113
2026-04-01CYTK66.60.310.32125016
2026-04-02CYTK66.720.320.19127345
2026-04-06CYTK64.930.324.73129700
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1



20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-03-09CYTK62.40-18.7-34.2-6.44
2026-03-10CYTK64.30-18.7-32.7-6.44
2026-03-11CYTK63.65-18.7-6.6-6.44
2026-03-12CYTK60.01-18.725.0-6.44
2026-03-13CYTK60.08-18.7-13.2-6.44
2026-03-17CYTK62.14-18.7-26.7-6.44
2026-03-18CYTK62.19-18.7-13.3-6.44
2026-03-19CYTK62.93-18.7-76.8-6.44
2026-03-20CYTK61.70-20.2-53.9-6.51
2026-03-23CYTK60.96-20.2-59.8-6.51
2026-03-24CYTK60.04-20.9-57.7-6.54
2026-03-25CYTK62.35-20.9-95.5-6.54
2026-03-26CYTK63.53-20.9-81.4-6.54
2026-03-27CYTK62.50-20.9-57.5-6.54
2026-03-30CYTK62.98-20.2-73.2-6.54
2026-03-31CYTK65.90-20.2-101.3-6.54
2026-04-01CYTK66.58-20.2-75.6-6.54
2026-04-02CYTK66.72-20.2-69.6-6.54
2026-04-06CYTK64.96-20.2-49.4-6.54
2026-04-07CYTK65.50-20.2-74.2-6.54
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1



20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-03-09CYTK-8.02-2.8412.28
2026-03-10CYTK-8.02-2.8412.28
2026-03-11CYTK-8.37-2.8412.77
2026-03-12CYTK-8.37-2.8412.77
2026-03-13CYTK-8.37-2.8412.77
2026-03-17CYTK-8.27-2.8412.77
2026-03-18CYTK-8.33-2.8412.77
2026-03-19CYTK-10.16-2.8412.77
2026-03-20CYTK-10.16-2.8412.77
2026-03-23CYTK-10.16-2.8312.77
2026-03-24CYTK-10.10-2.8312.77
2026-03-25CYTK-10.10-2.8313.01
2026-03-26CYTK-10.10-2.8313.01
2026-03-27CYTK-10.10-2.8313.01
2026-03-30CYTK-10.10-2.8513.01
2026-03-31CYTK-10.20-2.8513.01
2026-04-01CYTK-10.08-2.8513.01
2026-04-02CYTK-10.08-2.8513.01
2026-04-06CYTK-10.08-2.8613.01
2026-04-07CYTK-9.89-2.8613.01
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS​

-1.5

Avg. EPS Est. Current Quarter

-1.63

Avg. EPS Est. Next Quarter

-1.67

Insider Transactions

-9.89

Institutional Transactions

-2.86

Beta

0.46

Average Sales Estimate Current Quarter

9

Average Sales Estimate Next Quarter

16

Fair Value

Quality Score

9

Growth Score

43

Sentiment Score

71

Actual DrawDown %

40.6

Max Drawdown 5-Year %

-72.4

Target Price

93.22

P/E

Forward P/E

PEG

P/S

91.6

P/B

P/Free Cash Flow

EPS

-6.53

Average EPS Est. Cur. Y​

-6.54

EPS Next Y. (Est.)

-4.93

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-891.6

Relative Volume

0.68

Return on Equity vs Sector %

91.5

Return on Equity vs Industry %

108.1

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.03

EBIT Estimation

-74.2
◆ CYTK Healthcare
$65.48
📉
Swing / Pullback
Buy the dip on strong trends
28 /100
WEAK
Trend
0/20
Pullback
10/25
Volume
6/15
Valuation
8/20
TP/AR
4/10
Options
0/10
RSI
56.1
Range 1M
67.4%
Sup Dist
2%
🚀
Momentum Growth
Ride accelerating trends
N/A
23 /100
WEAK
Momentum
5/25
Growth
13/30
Estimates
3/20
Inst/Vol
2/15
Options
0/10
EPS Yr
1%
EPS NY
27.4%
52W%
86.5%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +42.4% upside
Quality
7/30
Valuation
10/30
Growth
9/25
Stability
8/10
LT Trend
1/5
Upside
+42.4%
Quality
9
Click a card to see score breakdown Full Analysis →
Cytokinetics, Incorporated
Sector: Healthcare
Industry: Biotechnology
Employees: 673
Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.
CYTK

Latest News

—
Caricamento notizie per CYTK…
stock quote shares CYTK – Cytokinetics, Incorporated Stock Price stock today
news today CYTK – Cytokinetics, Incorporated stock forecast ,stock prediction 2023 2024 2025
marketwatch CYTK – Cytokinetics, Incorporated yahoo finance google finance
stock history CYTK – Cytokinetics, Incorporated invest stock market
stock prices CYTK premarket after hours
ticker CYTK fair value insiders trading